|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales, net | |||||
| Quarta-Rad, Inc | |||||
| Sellavir, Inc. | |||||
| Total sales, net | |||||
| Cost of goods sold | |||||
| Quarta-Rad, Inc | |||||
| Sellavir, Inc. | |||||
| Gross profit | |||||
| Expenses: | |||||
| General and administrative | |||||
| Advertising | |||||
| Professional and consulting fees | |||||
| Operating expenses | |||||
| Net loss from operations | |||||
| Other income - interest and dividends | |||||
| Other expense - foreign currency translation loss | |||||
| Other income - foreign currency translation gain | |||||
| Other income - interest - related party | |||||
| Other expense - loss on loan modification | |||||
| Other income - unrealized gain (loss) on investments | |||||
| Other income - realized loss on investments | |||||
| Net loss before provision for income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Loss per share - basic | |||||
| Loss per share - diluted | |||||
| Weighted average shares - basic | |||||
| Weighted average shares - diluted | |||||
Loading...